Immutep IMMP
NASDAQ IMMP
$4.35 -0.19 (-4.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immutep (IMMP) Price to Sales (2017)

Updated

Immutep's (IMMP) Price to Sales stood at 0.30 in the year ended Jun 30, 2026, down 83.6% from 1.81 a year earlier.

Analysis

Immutep (IMMP) Price to Sales (2017) Analysis & Trends

Starting with the year ended Jun 30, 2012, Immutep's Price to Sales history includes 11 years.

  • The figure for the year ended Jun 30, 2026 is the lowest annual Price to Sales since the year ended Jun 30, 2022.
  • Per Business Quant data, IMMP's Price to Sales was 1.81 in the year ended Jun 30, 2025 and 0.00 in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Immutep 31.76 Mn 31.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 10.21
API Access

Immutep Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=IMMP&period=max&api_key=YOUR_API_KEY